Studien & Berichte

Whitepaper, Forschungsberichte und Marktdaten

#Overactive Bladder ×

Studien & Berichte

23. Aug. 2026•1 Min. Lesezeit

Mirabegron Study for OAB Completed

Astellas Pharma's mirabegron study for overactive bladder in China is completed. The study evaluated efficacy and safety of mirabegron.